Table 1 Patient characteristics at diagnosis.

From: Potential value of pre-planned imaging of bone disease in multiple myeloma

 

All

Cases of PBD

 

Age mean (range)

65.1 years

(42–83)

65.0 years

(48–82)

 
 

n

%

n

%

 

Gender (Male)

163

61.0

25

67.6

ns

Myeloma:

IgG

164

67.7

23

62.2

ns

IgA

48

14.6

8

21.6

ns

Light chain

55

17.7

6

16.2

ns

ISS at diagnosis

I

119

44.5

12

32.4

ns

II

97

36.3

19

51.4

ns

III

46

17.7

6

16.2

ns

Missing

5

1.9

0

0.0

ns

R-ISS at diagnosis

I

69

25.8

5

18.5

ns

II

109

40.8

19

51.4

ns

III

31

11.6

5

18.5

ns

Missing

58

21.7

8

17.0

ns

Performance status (inclusion)

0

157

58.8

14

37.8

P < 0.01

1

82

30.7

12

32.4

ns

2

15

5.6

5

13.5

ns

3

7

2.6

6

16.2

P < 0.01

4

1

0.4

0

0.0

ns

Missing

5

1.9

0

0.0

ns

Cytogenetics

t(4;14)

13

4.9

1

2.7

ns

t(14;16)

5

1.9

1

2.7

ns

del17p

12

4.5

2

5.4

ns

none of above

121

45.3

20

54.1

ns

missing

91

34.1

13

35.1

ns

  1. Patient characteristics. Distribution of gender, age, myeloma type, ISS, R-ISS and cytogenetics, diagnosis and performance status at diagnosis of patients included in study in all patients and in patients where progressive bone disease was found.